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Five months after a cadaveric renal transplant a 69-year-old man was admitted with caval, 
iliac, and renal allograft vein thrombosis that occurred in the setting of a previously placed 
caval filter. The patient's urine output and renal function deteriorated rapidly. Throm- 
bolytic therapy with urokinase was begun, and lysis of the thrombus occurred in 72 hours. 
The patient's renal function returned to baseline, and the transplant was salvaged. 
Moreover lower extremity venous patency and valvular fianction were maintained. We 
report the case and review the literature on thrombolytic therapy for renal allograft vein 
and lower extremity deep venous thrombosis. (J VASC SURG 1995;21:691-6.) 
Renal allograft vein thrombosis occurs in a small 
percentage of  renal transplant recipients but in the 
past has often resulted in loss of  the transplant. 1-3 
Restorat ion o f  allograft venous flow has most  fre- 
quently been attempted surgically.1 In this article we 
report the use of  thrombolyt ic therapy for the 
treatment o f  lilac, femoral, and allograft vein throm- 
bosis. This treatment resulted in salvage of  renal 
allograft function. Moreover  short-term venous pa- 
tency and valvular function were maintained. 
CASE REPORT 
A 69-year-old white man was admitted for mental 
status changes and hypoxia. Five months previously the 
patient had undergone cadaveric kidney transplantation for 
end-stage renal disease caused by hypertension. Anastomo- 
sis was performed on the renal allograft artery and vein in 
an end-to-side fashion to the left external iliac artery and 
vein, respectively. Two months before he was admitted, the 
patient had development of a left femoral deep venous 
thrombosis complicated by a pulmonary embolus. Initial 
treatment for the venous thromboembolic disease con- 
sisted of heparin sodium followed by warfarin anticoagu- 
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lation. However, 1 month before this admission the patient 
reported severe lumbosacral pain, and worknp demon- 
strated degenerative spinal disease. The anticoagulation 
was discontinued in anticipation of lumbar laminectomy, 
and a titanium Greenfield falter was placed in the infrarenal 
vena cava via a percutaneous right femoral approach. 
Physical examination at admission was remarkable for 
severe hypotension, obtundation, exquisite tenderness and 
fullness over the renal allograft, and abdominal distention. 
The lower abdomen and pelvis had cyanotic mottling that 
became confluent over both legs. The feet were cold and 
deeply cyanotic. Arterial oxygen saturation on 100% non- 
rebreather mask was 80%, and marked hemoconcentration 
was present with the hematocrit ncreased to 55% from a 
known baseline of 31%. The patient had anuria and a small 
amount of blood in the bladder drainage catheter. The 
serum creatinine level was elevated to 2.4 mg/dl from a 
baseline of 1.6 mg/dl and continued to rise at an anephric 
rate. Supportive measures resulted in normalization of the 
arterial blood pressure with no change in the appearance of
the lower extremities or urine output. Because Doppler- 
derived pedal arterial pressures were normal, a clinical diag- 
nosis of phlegmasia cerulea dolens and transplant renal vein 
thrombosis was made. Color flow duplex ultrasonography 
of the left lilac fossa renal allograft demonstrated decreased 
arterial diastolic flow, absent venous flow, and marked al- 
lograft enlargement. The external and common lilac veins 
bilaterally and the proximal left common femoral vein were 
thrombosed, and thrombus extended proximally in the in- 
ferior vena cava to the level of the Greenfield filter. Twenty 
thousand units of heparin sodium were administered. 
Emergency lilac and caval venography via a left femoral 
approach demonstrated occlusive thrombus extending 
from the proximal left common femoral vein to the inferior 
691 
JOURNAL OF VASCULAR SURGERY 
692 Killewich et al. April 1995 
Fig. 1. Venograph demonstrating thrombosis of left (LEIV) external i iac vein. Left common 
femoral vein (LCFV) is patent. Renal allograft vein is not visualized. 
vena cava at the level of the Greenfield filter. The renal 
allograft vein was not visualized (Figs. 1 and 2). Simulta- 
neous pressure measurements in the transplant renal vein 
and the vena cava above the Greenfield filter were 50 and 
8 mm Hg, respectively. With the use of the left femoral 
approach a catheter with multiple side holes was positioned 
from the common femoral vein to the caval filter, and 
urokinase infusion was begun at a rate of 240,000 U/hr. 
This infusion was continued for 4 hours and was then 
decreased to 100,000 U/hr overnight. The patient was also 
given 2500 U heparin sodium per hour, and the partial 
thromboplastin time was kept between 90 to 120 seconds. 
The fibrinogen level was monitored and remained between 
100 and 400 mg/dl throughout the infusion. 
Twenty-four hours after thrombolytic therapy was 
initiated, the patient remained anuric. The left foot was 
markedly improved, but the right foot was essentially 
unchanged. Venography revealed partial resolution of the 
left femoral, lilac, and caval thrombus (Fig. 3). The renal 
allograft vein pressure was equal to the systemic venous 
pressure. A second side hole catheter was placed into the 
thrombosed right iliac vein. Uroldnase was infused 
through the left-sided catheter at 60,000 U/hr and through 
the right-sided catheter at 120,000 U/hr. Complete reso- 
lution of the lower extremity cyanosis was present by the 
next day. The urokinase was discontinued, and the patient 
was given sufficient systemic heparin sodium to maintain 
the partial thromboplastin time between 80 and 100 
seconds. For the next 5 days the urine output gradually 
increased to polyuric levels and then normalized. The 
serum creatinine l vel peaked at 5.9 mg/dl before returning 
to a baseline of 1.2 mg/dl. Repeat renal duplex scanning on
the fifth hospital day demonstrated patency of the trans- 
plant renal artery and vein, the femoral and lilac veins 
bilaterally, and the inferior vena cava. Renal allograft 
swelling had improved as had the parenchymal arterial 
diastolic flow. Subsequent evaluation of fever, headache, 
and backache revealed Cr~tococcus neoformans meningitis 
and fungemia. Resolution of this infection was achieved 
with a 6-week course of amphotericin B. Anticoagulation 
was continued for approximately 30 days, until the patient 
had upper gastrointestinal bleeding that required transfu- 
sion of 4 units of blood; at this time the anticoagulation was 
discontinued. The patient was discharged on the seventy- 
fifth hospital day and was prescribed 325 mg aspirin daily. 
After 4 months he has no symptoms and is ambulatory. 
Repeat duplex scanning has demonstrated continued 
patency of all deep veins and competent lower extremity 
venous valves. 
DISCUSSION 
Renal allograft vein thrombosis is an unusual 
cause of  allograft dysfunction. Previous studies have 
documented an incidence of  1% to 4%. 1,2 However,  
in most  cases it has led to loss of  the allograft. The 
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Fig. 2. Venograph demonstrating thrombus in inferior vena cava (IVC) t level of Greenfield 
filter (GF). 
most common time of occurrence is in the early 
posttransplant period and is attributed to kinking of 
the vein in the iliac fossa, external compression from 
a hematoma, lymphocele, or abscess, use of multiple 
artery or pediatric kidneys, or rejection. 3 Late throm- 
bosis is attributed to rejection, glomerulonephritis, 
or extension of lower extremity deep venous throm- 
bosis) 
Treatment of renal allograft vein thrombosis has 
traditionally been surgical, but the results have been 
disappointing. In most cases the graft was lost, and in 
many it was nonviable at the time of exploration. 4 
The increased availability and success ofthrombolytic 
therapy has led to its use for the treatment of renal 
allograft vein thrombosis. Five case reports have been 
published in which patients underwent successful 
thrombolysis and restoration of renal function with 
streptokinase orurokinase.59 The presentation ofthe 
patient in most cases was nonspecific and was 
suggestive of rejection with aUograft tenderness, 
decreased urine output, and elevated creatinine. In 
two of the five cases 7,8 lower extremity edema 
suggesting the presence of deep venous thrombosis 
was present. Two patients had histories of lower 
extremity deep venous thrombosis, '8 
Diagnosis in the published reports was made by 
duplex ultrasonography or venography. The duplex 
scan demonstrates absence of venous flow and 
changes in the arterial flow pattern including abruptly 
decreasing systolic frequency shifts and retrograde 
plateanlike shifts during diastole. It has the advantage 
of not requiring intravenous contrast, which can be 
harmful to renal function. Venography, however, 
remains the gold standard and is necessary to direct 
lyric therapy. 
In the previously published reports thrombolytic 
therapy was infused via the renal allograft artery in 
two cases, 6,9 the renal allograft vein in two cases, '8 
and via both vessels in one case. 7 Catheter location 
did not affect he success ofthrombolysis or the rate. 
In all reported cases ~9 and, in our case, patients 
experienced decreased urine output and renal func- 
tion associated with allograft vein thrombosis. After 
lyric therapy was initiated, radiologic progression of 
lysis paralleled increasing urine output. However, 
recovery of renal function as demonstrated by de- 
creasing crearininc lagged lysis by several days. In the 
case of our patient 48 hours after lyric therapy was 
begun, most of the thrombus was gone, and the urine 
output averaged 150 cc/hr. The creatinine concen- 
tration, however, continued to rise for 3 additional 
days, reaching a peak of 5.9 mg/di. It returned to 
baseline approximately 1 week later. 
Lytic therapy for renal allograft vein thrombosis 
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Fig. 3. Venograph demonstrating partial resolution of left external iliac (LEIIO thrombus. Left 
common femoral and common iliac veins are patent. 
appears to be efficacious in cases where it results 
from accompanying deep venous thrombosis. 
Clearly in cases of compression by lymphocele or 
hematoma or kinking of the allograft vessels, a r dio- 
logic or surgical procedure would also be required to 
maintain venous patency. Moreover, early diagnosis 
and emergent therapy is essential to preserve renal 
function. 
The mechanism ofcaval thrombosis n this case is 
not clear. Caval thrombosis from titanium Greenfield 
filters occurs in only 5% of patients. Preliminary 
results of a long-term study currently in progress in 
our laboratory have demonstrated an incidence of 2% 
at 2 years. Deep venous thrombosis with proximal 
progression of thrombus at the insertion site is also 
unusual, occurring in approximately 6% of pa- 
tients. ~° Laboratory data have failed to demonstrate 
any abnormalities ofantithrombin III, protein C, or 
protein S in this patient. The most likely mechanism 
of thrombosis may have been embolic occlusion of 
the filter with subsequent iliac and femoral throm- 
bosis. In this case it is also noteworthy that the 
episode of fungal sepsis was treated successfully 
without infection of the filter. Previous tudies have 
documented the resistance to infection of Greenfield 
filters in the setting of bacteremia? ° 
Rapid lysis of the caval, iliac, and femoral 
thrombus in this patient resulted in preservation fa 
patent lower extremity venous ystem 4months later. 
Color flow duplex scanning demonstrated complete 
recanalization of the deep venous thrombosis and 
preservation fvenous valvular function. In the past 
the use of thrombolytic therapy for venous throm- 
boembolic disease has been controversial. A number 
of studies evaluating its short-term efficacy by com- 
paring pretreatment and posttreatment venography 
have been published. 1119 The studies are difficult o 
interpret because of small size, inadequacy of ran- 
domization and blinding, and different reatment 
regimens. Nevertheless, taken together they suggest 
that more lysis occurred in groups of patients who 
received lyric therapy with streptokinase than in those 
who received heparin only. 2° A compilation of the 
results of nine randomized studies including 297 
patients divided into those who received streptoki- 
nase plus anticoagulation a d those who received 
anticoagulation alone found similar esults. Sixty-one 
percent of the patients who received streptokinase 
demonstrated some improvement on postrreatment 
venography, and 45% showed substantial improve- 
ment. In contrast, only 25% of patients treated with 
anticoagulation alone demonstrated any improve- 
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ment, and only 5% demonstrated substantial im- 
provement. 2° 
The long-term benefit of thrombolyric therapy in 
the treatment of deep venous thrombosis less well 
proven. Ideally rapid lysis of thrombus hould pre- 
serve venous valvular function. This function in turn 
should prevent he development of the postthrom- 
boric syndrome and its debilitating symptoms of 
lower extremity pain, edema, and ulceration. Unfor- 
tunately, it has been difficult o demonstrate a benefit 
of thrombolyric therapy in preventing the develop- 
ment of chronic venous insufficiency. Studies as- 
sessing the long-term benefit have been pub- 
lished, 16'I8'19'21-24 but they are small, uncontrolled, 
and have produced conflicting results. Moreover, the 
follow-up periods are usually too short to allow for 
full development of chronic venous insufficiency inall 
patients. In one study of streptokinase treatment, 25 
patients with residual thrombus were more likely to 
have symptoms of chronic venous insufficiency than 
were those with early complete lysis. However, a 
study of 153 patients evaluated prospectively for 2 
years after treatment with streptokinase or heparin 
showed no difference in clinical or hemodynamic 
measurements of chronic venous insufficiency in ei- 
ther group.  26 
Our patient initially experienced a limited deep 
venous thrombosis in the common femoral vein, 
which was treated only with anticoagularion. The 
episode described in this report, treated with lytic 
therapy, was much more extensive. Four months 
after the second episode our patient's venous ystem 
remains patent with normal valvular function by 
duplex scanning. It is clearly too early to tell 
whether he will have chronic venous insufficiency, 
but our initial findings are promising. In a previous 
study, 27 valvular incompetence was present 3 
months after development of acute deep venous 
thrombosis. Moreover, although anticoagulation 
during his initial limited episode of thrombosis 
may have been effective in preventing valvu- 
lar incompetence, it is unlikely to have been suc- 
cessful in preventing destruction of valves asso- 
ciated with the much more extensive throm- 
bosis that developed the second time. Studies 
have also demonstrated that valve destruction most 
often occurs in areas that have previously been 
th rombosed,  27'28 suggesting that it results from 
direct injury to the valves by the thrombus. Al- 
though lyric therapy might not be beneficial in 
limited deep venous thrombosis, it may be helpful 
in preserving valvular function in extensive cases, if 
initiated early. 
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